Document:

Exhibit 10.26

 

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING,
THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES.

 

	Warrant Shares: [______________]	Issue Date: January __, 2019

 

COMMON STOCK PURCHASE WARRANT

 

BioHiTech Global, Inc., a corporation
organized under the laws of the State of Delaware (the “Company”), hereby certifies that, for value received,
[_____________________] or its assigns (the “Holder”), is entitled, subject to the terms and limitations on
exercise and conditions hereinafter set fifth below, to purchase from the Company at any time after the Issue Date until 5:00 p.m.,
E.S.T on the fifth anniversary of the Issue Date (the “Termination Date”), up to [________________]fully paid
and nonassessable shares of Common Stock at a per share purchase price of $3.50 (the “Exercise Price”). The
number and character of such shares of Common Stock and the Exercise Price are subject to adjustment as provided herein. The Company
may reduce the Exercise Price for some or all of the Warrants, temporarily or permanently, provided such reduction is made as to
all outstanding Warrants for all Holders of such Warrants

 

As used herein the following
terms, unless the context otherwise requires, have the following respective meanings:

 

(a)          The
term “Company” shall mean BioHiTech Global, Inc., a Delaware corporation, and any corporation which shall succeed
or assume the obligations of BioHiTech Global, Inc. hereunder.

 

(b)          The
term “Common Stock” includes (i) the Company's Common Stock, $0.0001 par value per share, as authorized as of
the date hereof, and (ii) any other securities into which or for which any of the securities described in (i) may be converted
or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

 

(c)          The
term “Other Securities” refers to any stock (other than Common Stock) and other securities of the Company or
any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have
received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or
shall have been issued in exchange for or in replacement of Common Stock or Other Securities pursuant to Section 3 or otherwise.

 

    	 	1	 

     

    

 

(d)          The
term “Warrant Shares” shall mean the Common Stock issuable upon exercise of this Warrant.

 

1.            Exercise
of Warrant.

 

1.1.          Number
of Shares Issuable upon Exercise. From and after the Issue Date through and including the Termination Date, the Holder hereof
shall be entitled to receive, upon exercise of this Warrant in whole in accordance with the terms of subsection 1.2 or upon exercise
of this Warrant in part in accordance with subsection 1.3, shares of Common Stock of the Company, subject to adjustment pursuant
to Section 3.

 

1.2.          Full
Exercise. This Warrant may be exercised in full by the Holder hereof by delivery of an original or facsimile copy of the form
of exercise notice attached as Exhibit A hereto (the “Notice of Exercise”) duly executed by such Holder and
delivery within two days thereafter of payment, in cash, wire transfer or by certified or official bank check payable to the order
of the Company, in the amount obtained by multiplying the number of shares of Common Stock for which this Warrant is then exercisable
by the Exercise Price then in effect. The original Warrant is not required to be surrendered to the Company until it has been fully
exercised.

 

1.3.          Partial
Exercise. This Warrant may be exercised in part (but not for a fractional share) by delivery of a Notice of Exercise in the
manner and at the place provided in subsection 1.2 except that the amount payable by the Holder on such partial exercise shall
be the amount obtained by multiplying (a) the number of whole shares of Common Stock designated by the Holder in the Notice
of Exercise by (b) the Exercise Price then in effect. On any such partial exercise provided the Holder has surrendered the
original Warrant, the Company, at its expense, will forthwith issue and deliver to or upon the order of the Holder hereof a new
Warrant of like tenor, in the name of the Holder hereof or as such Holder (upon payment by such Holder of any applicable transfer
taxes) may request, the whole number of shares of Common Stock for which such Warrant may still be exercised.

 

1.4.          Company
Acknowledgment. The Company will, at the time of the exercise of the Warrant, upon the request of the Holder hereof, acknowledge
in writing its continuing obligation to afford to such Holder any rights to which such Holder shall continue to be entitled after
such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure
shall not affect the continuing obligation of the Company to afford to such Holder any such rights.

 

1.5.          Delivery
of Stock Certificates, etc. on Exercise. The Company agrees that, provided the full Exercise Price listed in the Notice of
Exercise is received as specified in Section 1.2 or Section 1.3, the shares of Common Stock purchased upon exercise of this Warrant
shall be deemed to be issued to the Holder hereof as the record owner of such shares as of the close of business on the date on
which delivery of a Notice of Exercise shall have occurred and payment (if applicable) made for such shares as aforesaid. As soon
as practicable after the exercise of this Warrant in full or in part, and in any event within three (3) business days thereafter
(“Warrant Share Delivery Date”), the Company at its expense (including the payment by it of any applicable issue
taxes) will cause to be issued in the name of and delivered to the Holder hereof, or as such Holder (upon payment by such Holder
of any applicable transfer taxes) may direct in compliance with applicable securities laws, (1) provided that (x) the Transfer
Agent is participating in DTC Fast Automated Securities Transfer Program and (y) such Warrant Shares to be so issued are eligible
for resale pursuant to Rule 144, such aggregate number of Warrant Shares to which such Holder shall be entitled to such Holder’s
or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if either of the immediately
preceding clauses (x) or (y) are not satisfied, a certificate or certificates for the number of duly and validly issued, fully
paid and non-assessable shares of Common Stock (or Other Securities) to which such Holder shall be entitled on such exercise, plus,
in lieu of any fractional share to which such Holder would otherwise be entitled, at the Company’s option an additional share
of Common Stock by rounding up to the next whole share or cash equal to such fraction multiplied by the then Fair Market Value
of one full share of Common Stock, together with any other stock or other securities and property (including cash, where applicable)
to which such Holder is entitled upon such exercise pursuant to Section 1 or otherwise. The Company understands that a delay
in the delivery of the Warrant Shares after the Warrant Share Delivery Date could result in economic loss to the Holder.

 

    	 	2	 

     

    

 

2.            Adjustment
for Reorganization, Consolidation, Merger, etc.

 

2.1.          Fundamental Transaction.
If, at any time while this Warrant is outstanding, (A) the Company effects any Fundamental Transaction (as defined in the Certificate
of Designation of the Series D Cumulative Convertible Preferred Stock of the Company) then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder, upon exercise of this Warrant, the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and
any additional consideration (the “Alternate Consideration”) receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a Holder of the number of shares of Common Stock for which
this Warrant is exercisable immediately prior to such event. For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company
or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions
and evidencing the Holder's right to exercise such warrant into Alternate Consideration.  The terms of any agreement pursuant
to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply
with the provisions of this Section 2.1 and insuring that this Warrant (or any such replacement security) will
be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction.

 

    	 	3	 

     

    

 

2.2.          Continuation
of Terms. Upon any reorganization, consolidation, merger or transfer (and any dissolution following any transfer) referred
to in Section 2.1, this Warrant shall continue in full force and effect and the terms hereof shall be applicable to the Other Securities
and property receivable on the exercise of this Warrant after the consummation of such reorganization, consolidation or merger
or the effective date of dissolution following any such transfer, as the case may be, and shall be binding upon the issuer of any
Other Securities, including, in the case of any such transfer, the person acquiring all or substantially all of the properties
or assets of the Company, whether or not such person shall have expressly assumed the terms of this Warrant as provided in Section 2.1.

 

2.3           Share
Issuance. If, at any time while this Warrant is outstanding, the Company or any Subsidiary, as applicable, sells or grants
any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant
or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents (as defined in the Certificate of
Designation of the Series D Cumulative Convertible Preferred Stock of the Company) entitling any Person to acquire shares of Common
Stock at or with a conversion formula that creates an effective price per share that is lower than the then Exercise Price (such
lower price or conversion formula, the “Base Exercise Price” and such issuances, collectively, a “Dilutive Issuance”)
(if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of exercise price
adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights
per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price
per share that is lower than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price
on such date of the Dilutive Issuance), then the Exercise Price shall be reduced to equal the Base Exercise Price. Such adjustment
shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding the foregoing, no adjustment will
be made under this Section 2.3 in respect of an Exempt Issuance (as defined in the Certificate of Designation of the Series D Cumulative
Convertible Preferred Stock of the Company).

 

3.            Extraordinary
Events Regarding Common Stock. In the event that the Company shall (a) issue additional shares of the Common Stock as
a dividend or other distribution on outstanding Common Stock, (b) subdivide its outstanding shares of Common Stock, or (c) combine
its outstanding shares of the Common Stock into a smaller number of shares of the Common Stock, then, in each such event, the Exercise
Price shall, simultaneously with the happening of such event, be adjusted by multiplying the then Exercise Price by a fraction,
the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such event and the denominator
of which shall be the number of shares of Common Stock outstanding immediately after such event, and the product so obtained shall
thereafter be the Exercise Price then in effect. The Exercise Price, as so adjusted, shall be readjusted in the same manner upon
the happening of any successive event or events described herein in this Section 3. The number of shares of Common Stock that
the Holder of this Warrant shall thereafter, on the exercise hereof, be entitled to receive shall be adjusted to a number determined
by multiplying the number of shares of Common Stock that would otherwise (but for the provisions of this Section 3) be issuable
on such exercise by a fraction of which (a) the numerator is the Exercise Price that would otherwise (but for the provisions of
this Section 3) be in effect, and (b) the denominator is the Exercise Price in effect on the date of such exercise.

 

    	 	4	 

     

    

 

4.            Certificate
as to Adjustments. In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable
on the exercise of the Warrants, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate
designee to compute such adjustment or readjustment in accordance with the terms of the Warrant and prepare a certificate setting
forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including
a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other
Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities)
outstanding or deemed to be outstanding, and (c) the Exercise Price and the number of shares of Common Stock to be received upon
exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided
in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder of the Warrant and any Warrant Agent
of the Company (appointed pursuant to Section 8 hereof).

 

5.            Reservation
of Stock, etc. Issuable on Exercise of Warrant; Financial Statements. The Company will at all times reserve and keep available,
solely for issuance and delivery on the exercise of the Warrants, all shares of Common Stock (or Other Securities) from time to
time issuable on the exercise of the Warrant.

 

6.            Assignment;
Exchange of Warrant. Subject to compliance with applicable securities laws, this Warrant, and the rights evidenced hereby,
may be transferred by any registered holder hereof (a “Transferor”). On the surrender for exchange of this Warrant,
with the Transferor's endorsement in the form of Exhibit B attached hereto (the “Transferor Endorsement Form”)
and together with an opinion of counsel reasonably satisfactory to the Company that the transfer of this Warrant will be in compliance
with applicable securities laws, the Company will issue and deliver to or on the order of the Transferor thereof a new Warrant
or Warrants of like tenor, in the name of the Transferor and/or the transferee(s) specified in such Transferor Endorsement Form
(each a “Transferee”), calling in the aggregate on the face or faces thereof for the number of shares of Common
Stock called for on the face or faces of the Warrant so surrendered by the Transferor.

 

7.            Replacement
of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this Warrant, on delivery of an indemnity agreement or
security reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation
of this Warrant, the Company at its expense, twice only, will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

8.            Warrant
Agent. The Company may, by written notice to the Holder of the Warrant, appoint an agent (a “Warrant Agent”)
for the purpose of issuing Common Stock (or Other Securities) on the exercise of this Warrant pursuant to Section 1, exchanging
this Warrant pursuant to Section 6, and replacing this Warrant pursuant to Section 7, or any of the foregoing, and thereafter
any such issuance, exchange or replacement, as the case may be, shall be made at such office by such Warrant Agent.

 

    	 	5	 

     

    

 

9.            Transfer
on the Company's Books. Until this Warrant is transferred on the books of the Company, the Company may treat the registered
holder hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

10.           Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or facsimile, addressed as set forth in the Securities Exchange Agreement or to such other address
as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to
be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated
by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal
business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received) or (b) on the second business day following
the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur.

 

11.          Law
Governing This Warrant. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware
without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Warrant shall be brought only in the state courts of New York or in the federal courts located in the state
and county of New York. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
The Company and Holder waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable
attorney's fees and costs. In the event that any provision of this Warrant or any other agreement delivered in connection herewith
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the
extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision
which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of
any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit,
action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

(Signature page to follow.)

 

    	 	6	 

     

    

 

IN WITNESS WHEREOF, the Company
has executed this Warrant as of the date first written above.

 

	 	BIOHITECH GLOBAL, INC.
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

    	 	7Exhibit 10.1

 

One Madison Corporation

3 East 28nd Street, 8rd Floor

New York, New York 10016

 

May 13, 2019

 

One Madison Group LLC

23 East 22nd Street, 53rd Floor

New York, New York 10010

 

		RE:	Amendment No. 2 to the Securities Subscription Agreement

 

This second amendment (this “Amendment”)
to that certain Securities Subscription Agreement (the “Agreement”) entered into on July 18, 2017, as amended
on December 1, 2017, by and between One Madison Group LLC, a Delaware limited liability company (the “Subscriber”
or “you”), and One Madison Corporation, a Cayman Islands exempted company (the “Company”,
“we” or “us”) is made on the date hereof pursuant to Section 6.4 of the Agreement. Capitalized
terms that are used herein, except as otherwise defined herein, shall have the meanings ascribed to them in the Agreement. In consideration
of the mutual promises and covenants contained herein, the Company and the Subscriber agree as follows (subject to the last sentence
of this Amendment):

 

		1.	Section 3.4 of the Agreement shall be amended and
restated in its entirety to read as follows:

 

		3.4	Earnout.

 

(a) First
Earnout. During the period commencing on the date that a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination between the Company and one or more businesses (a “Business
Combination”) is consummated through the tenth anniversary following the consummation of such Business Combination
(the “Earnout End Date”), unless (a) the closing price of the Company’s Class A ordinary shares (or
any successor class of common shares listed on The New York Stock Exchange or The Nasdaq Stock Market) equals or exceeds
$15.00 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20
trading days within any 30 consecutive trading day period or (b) the Company completes a liquidation, merger, share exchange
or other similar transaction that results in all of its common shareholders having the right to exchange their common equity
for consideration in cash, securities or other property or any transaction involving a consolidation, merger, proxy contest,
tender offer or similar transaction in which the Company is the surviving entity which results in a change in the majority of
our board of directors or management team or the company’s stockholders immediately prior to such transaction ceasing
to own a majority of the surviving entity immediately after such transaction (each a “First Earnout
Condition”), on the Earnout End Date or promptly thereafter (the “Earnout Forfeiture Date”), the
Subscriber acknowledges and agrees that it shall surrender for no consideration any and all rights to such number of
Shares (including any Class A ordinary shares or Class C ordinary shares into which such Shares have converted) equal to
50.0% of the Shares held by the Subscriber immediately following the Company’s IPO (after accounting for any
forfeitures required pursuant to Section 3.2 hereto but assuming no exercise of the Over-allotment Option), or 3,397,500
Shares (the “First Earnout Shares”).

 

(a) Second
Earnout. During the period commencing on the date that a Business Combination is consummated through the Earnout End
Date, unless (a) the closing price of the Company’s Class A ordinary shares (or any successor class of common shares
listed on The New York Stock Exchange or The Nasdaq Stock Market) equals or exceeds $17.00 per share (as adjusted for share
splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading
day period or (b) the Company completes a liquidation, merger, share exchange or other similar transaction that results in
all of its common shareholders having the right to exchange their common equity for consideration in cash, securities or
other property or any transaction involving a consolidation, merger, proxy contest, tender offer or similar transaction in
which the Company is the surviving entity which results in a change in the majority of our board of directors or management
team or the company’s stockholders immediately prior to such transaction ceasing to own a majority of the surviving
entity immediately after such transaction (each a “Second Earnout Condition”), on the Earnout Forfeiture
Date, the Subscriber acknowledges and agrees that it shall surrender for no consideration any and all rights to such number
of Shares (including any Class A ordinary shares or Class C ordinary shares into which such Shares have converted) equal to
50.0% of the Shares held by the Subscriber immediately following the Company’s IPO (after accounting for any
forfeitures required pursuant to Section 3.2 hereto but assuming no exercise of the Over-allotment Option), or 3,397,500
Shares (the “Second Earnout Shares”).

 

     

     

    

 

(d) Dividends.
The First Earnout Shares and the Second Earnout Shares (including any Class A ordinary shares or Class C ordinary shares into
which such shares have converted) will not participate in cash dividends or other cash distributions payable to holders of
the ordinary shares of the Company prior to the date on which one or more of the First Earnout Conditions or the Second
Earnout Conditions, respectively, has been satisfied, whereupon the Company shall promptly pay to the Subscriber in respect
of the First Earnout Shares or the Second Earnout Shares (including any Class A ordinary shares or Class C ordinary shares
into which such shares have converted), as applicable, all cash dividends and cash distributions paid on the ordinary shares
of the Company after the Ranpak Business Combination as if they had been holders of record entitled to receive distributions
on the applicable record date.

 

(c) Redemption
of Public Shares. In the event that any of the Shares held by the Subscriber are forfeited to the Company as a result of
the redemption of the Company’s Class A Shares in connection with the shareholder vote to approve the Business
Combination, such forfeitures will reduce first, the Second Earnout Shares and next, the First Earnout Shares.

 

		2.	Section 5.4 of the Agreement shall be amended and
restated in its entirety to read as follows:

 

5.4
“Subscriber Lock-up. The Subscriber agrees that it shall not (and shall cause any employees of the Subscriber
and/or the Company to whom the Subscriber Transfers Shares not to) Transfer any (i) First Earnout Shares until the earlier of
(A) the date on which one or more of the First Earnout Conditions has been satisfied and (B) the Earnout Forfeiture Date and
(ii) Second Earnout Shares until the earlier of (A) the date on which one or more of the Second Earnout Conditions has
been satisfied and (B) the Earnout Forfeiture Date, unless the transferee enters into a written agreement for the benefit of
the Company, in a form reasonably acceptable to the Company, agreeing to be bound by the terms of this Agreement.”

 

Upon and after the effectiveness of this
Amendment, each reference in the Agreement to “this Agreement”, “hereunder”, “hereof” or words
of like import referring to the Agreement shall mean and be a reference to the Agreement as modified and amended hereby.

 

This Amendment may be executed in one or
more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such signature page were an original thereof.

 

This Amendment and the rights and obligations
of the parties hereunder shall be construed in accordance with and governed by the laws of New York applicable to contracts wholly
performed within the borders of such state, without giving effect to the conflict of law principles thereof.

 

This Amendment is the joint product of the
Subscriber and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of
such parties and shall not be construed for or against any party hereto.

 

If the Stock Purchase Agreement referenced
above is terminated prior to the consummation of the Business Combination, this Amendment shall automatically be deemed null and
void ab initio.

 

[Signature Page Follows]

 

    2

     

    

 

If the foregoing accurately
sets forth our understanding and agreement, please sign the enclosed copy of this Amendment and return it to us.

 

	 	Very truly yours,
	 	 
	 	ONE MADISON CORPORATION
	 	 
	 	By:	/s/ Omar M. Asali
	 	 	Name: 	Omar M. Asali
	 	 	Title:	Chief Executive Officer

 

Accepted and agreed as of the date first written above.

 

	ONE MADISON GROUP LLC	 
	 	 
	By:	/s/ Omar M. Asali	 
	 	Name: 	Omar M. Asali	 
	 	Title:	Sole Member

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]